Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma

International Journal of Laboratory Hematology

Volumn 30, Issue 1, 2008, Pages 75-81

  Toubai, T ^a   Hirate, D ^a   Shono, Y ^a   Ota, S ^a   Ibata, M ^a   Mashiko, S ^a   Sugita, J ^a   Shigematsu, A ^a   Miura, Y ^a   Kato, N ^a   Umehara, S ^a   Kahata, K ^a   Tsutsumi, Y ^b   Iwao, N ^a   Toyoshima, N ^a   Tanaka, J ^a   Asaka, M ^a   Imamura, M ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hakodate Municipal Hospital   (Japan)

Author keywords

Chimerism; Cord blood transplantation; Multiple myeloma; TCR repertoire; Viral infection

Indexed keywords

ACICLOVIR; BENCE JONES PROTEIN; BUSULFAN; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; T LYMPHOCYTE RECEPTOR;

ADENOVIRUS; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CHIMERA; CYTOMEGALOVIRUS; GRAFT VERSUS HOST REACTION; HEPATITIS B VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; JAPANESE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; REMISSION; SEROLOGY; UMBILICAL CORD BLOOD; VARICELLA ZOSTER VIRUS; WHOLE BODY RADIATION;

AGED; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MULTIPLE MYELOMA; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; VIRUS DISEASES;

EID: 38049022166     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00903.x     Document Type: Article

References (29)

1. Ando T., Yujiri T., Tominaga T., Shinya S., Takahashi T., Nomiyama J., Seguchi M., Matsubara A., Fujii Y. Tanizawa Y. (2005) Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity. European Journal of Haematology 74, 175 179.
2. Arden B., Clark S.P., Kabelitz D. Mak T.W. (1995) Human T-cell receptor variable gene segment families. Immunogenetics 42, 455 500.
3. Attal M., Harousseau J.L., Facon T., Guilhot F., Doyen C., Fuzibet J.G., Monconduit M., Hulin C., Caillot D., Bouabdallah R., Voillat L., Sotto J.J., Grosbois B. Bataille R., InterGroupe Francophone du Myeloma 2003) Single versus double autologous stem-cell transplantation for multiple myeloma. New England Journal of Medicine 349, 2495 2502.
4. Badros A., Barlogie B., Siegel E., Cottler-Fox M., Zangari M., Fassas A., Morris C., Anaissie E., Van Rhee F. Tricot G. (2002) Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. Journal of Clinical Oncology 20, 1295 1303.
5. Barker J.N., Weisdorf D.J., De For T.E., Blazar B.R., Miller J.S. Wagner J.E. (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced intensity conditioning. Blood 102, 1915 1919.
6. Bensinger W.I., Buckner C.D., Anasetti C, Clift R., Storb R., Barnett T., Chauncey T., Shulman H. Appelbaum F.R. (1996) Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. Blood 88, 2787 2793.
7. Bjorkstrand B., Ljungman P., Svensson H., Hermans J., Alegre A., Apperley J., Blade J., Carlson K., Cavo M., Ferrant A., Goldstone A.H., de Laurenzi A., Majolino I., Marcus R., Prentice H.G., Remes K., Samson D., Sureda A., Verdonck L.F., Volin L. Gahrton G. (1996) Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 88, 4711 4718.
8. Child J. A., Morgan G. J., Davies F. E., Owen R. G., Bell S. E., Hawkins K., Brown J., Drayson M. T., Selby P. J., Medical Research Council Adult Leukemia Working Party 2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New England Journal of Medicine 348, 1875 1883.
9. Crawley C., Lalancette M., Szydlo R., Gilleece M., Peggs K., Mackinnon S., Juliusson G., Ahlberg L., Nagler A., Shimoni A., Sureda A., Boiron J.M., Einsele H., Chopra R., Carella A., Cavenagh J., Gratwohl A., Garban F., Zander A., Bjorkstrand B., Niederwieser D., Gahrton G. Apperley JF., Chronic Leukemia Working Party of the EBMT 2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT. Blood 105, 4532 4539.
10. Gahrton G., Tura S., Ljungman P., Blade J., Brandt L., Cavo M., Facon T., Gratwohl A., Hagenbeek A. Jacobs P. (1995) Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. Journal of Clinical Oncology 13, 1312 1322.
11. Grewal S.S., Barker J.N., Davies S.M. Wagner J.E. (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101, 4233 4244.
12. Hahn T., Wingard J. R., Anderson K. C., Bensinger W. I., Berenson J. R., Brozeit G., Carver J. R., Kyle R. A. McCarthy Jr. P. L. (2003) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biology of Blood and Marrow Transplantation 9, 4 37.
13. Hentschke P., Omazic B., Mattsson J., Nasman-Bjork I., Lundkvist I., Gigliotti D., Barkholt L., Ringden O. Remberger M. (2005) T-cell receptor Vb repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Scandinavian Journal of Immunology 61, 285 294.
14. Kroger N., Schwerdtfeger R., Kiehl M., Sayer H.G., Renges H., Zabelina T., Fehse B., Togel F., Wittkowsky G., Kuse R. Zander A.R. (2002a) Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood 100, 755 760.
15. Kroger N, Sayer H.G., Schwerdtfeger R., Kiehl M., Nagler A., Renges H., Zabeline T., Fehse B., Ayuk F., Wittkowsky G., Schmitz N. Zander A.R. (2002b) Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. Blood 100, 3919 3924.
16. Lim S.H., Badros A., Lue C. Barlogie B. (2001) Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma. Cancer 91, 900 908.
17. Maloney D.G., Molina A.J., Sahebi F., Stockeri-Goldstein K.E., Sandmaier B.M., Bensinger W., Storer B., Hegenbart U., Somlo G., Chauncey T., Bruno B., Appelbaum F.R., Blume K.G., Forman S.J., McSweeney P. Storb R. (2003) Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 101, 3447 3454.
18. Mariani S., Coscia M., Even J., Peola S., Foglietta M., Boccadoro M., Sbaiz L., Restagno G., Pileri A. Massaia M. (2001) Severe and long-lasting distruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. British Journal of Haematology 113, 1051 1059.
19. Miyakoshi S., Yuji K., Kami M., Kusumi E., Kishi Y., Kobayashi K., Murashige N., Hamaki T., Kim S.W., Ueyama J., Mori S., Morinaga S., Muto Y., Masuo S., Kanemaru M., Hayashi T., Takaue Y. Taniguchi S. (2004) Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clinical Cancer Research 10, 3586 3592.
20. Mohty M., Boiron J.M., Damaj G., Michallet A.S., Bay J.O., Faucher C., Perreau V., Bilger K., Coso D., Stoppa A.M., Tabrizi R., Gastaut J.A., Michallet M., Maraninchi D. Blaise D. (2004) Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation 34, 77 84.
21. Narimatsu H., Kami M., Miyakoshi S., Yuji K., Hamaki T., Masuoka K., Kusumi E., Kishi Y., Matsumura T., Wake A., Morinaga S., Kanda Y. Taniguchi S. (2005) Graft failure following reduced-intensity cord blood transplantation for adult patients. British Journal of Haematology 132, 36 41.
22. Orsini E., Alyea E.P., Schlossman R., Canning C., Soiffer R.J., Chillemi A., Neuberg D., Anderson K.C. Ritz J. (2000) Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplantation 25, 623 632.
23. Perez-Simon J.A., Martino R., Alegre A., Tomas J.F., De Leon A., Caballero D., Sureda A., Sierra J. San Miguel J.F. (2003) Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation. British Journal of Haematology 121, 104 108.
24. Puisieux I., Even J., Pannetier C., Jotereau F., Favrot M. Kourilsky P. (1995) Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. Journal of Immunology 153, 2807 2818.
25. Sarzotti M., Patel D.D., Li X., Ozaki D.A., Cao S., Langdon S., Parrott R.E., Coyne K. Buckley R.H. (2003) T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. The Journal of Immunology 170, 2711 2718.
26. Talvensaari K., Clave E., Douay C., Rabian C., Garderet L., Busson M., Garnier F., Douek D., Gluckman E., Charron D. Toubert A. (2002) A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99, 1458 1464.
27. Tsutsumi Y., Tanaka J., Kato N., Zhang L., Mori A., Kobayasi R., Kasai M., Asaka M. Imamura M. (2002) Analysis of mixed chimerism in patients after allogeneic stem cell transplantation using a capillary electrophoresis system. Acta Haematologica 107, 195 202.
28. Tsutsumi Y., Tanaka J., Miura Y., Toubai T., Kato N., Fujisaw F., Toyoshima N., Ota S., Mori A., Yonezumi M., Chiba K., Kondo T., Hasino S., Kobayasi R., Masauji N., Kasai M., Asaka M. Imamura M. (2004) Molecular analysis of T-cell repertoire in patients with Graft-Versus-host disease after allogeneic stem cell transplantation. Leukemia and Lymphoma 45, 481 488.
29. Yamada T., Tomonari A., Takahashi S., Ooi J., Iseki T., Shimohakamada Y., Takasugi K., Ohno N., Nagamura F., Uchimaru K., Tojo A., Moriwaki H. Asano S. (2004) Unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous transplantation for multiple myeloma. International Journal of Hematology 80, 377 380.